Tesamorelin

Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), engineered with a modified sequence to increase stability and bioavailability. It has been studied as a research tool for stimulating endogenous growth hormone (GH) secretion and its downstream effects on metabolism.

In preclinical and clinical studies, Tesamorelin has been shown to promote GH release, leading to elevations in insulin-like growth factor-1 (IGF-1). These changes have been associated with shifts in body composition, such as reduced visceral adipose tissue and altered lipid metabolism, making Tesamorelin useful in research exploring energy balance, fat distribution, and age-related endocrine decline. Simply put, it's primarily used to reduce excess stomach fat, commonly known as abdominal lipodystrophy.

All products are intended for in vitro or laboratory research use only. This compound is not intended for therapeutic or diagnostic purposes and has not been approved by the FDA for human or veterinary use.

** This product is in lyophilized powder form and requires reconstitution solution (BAC Water) for research.